Safety assessment of plant food supplements (PFS)

Food and Function

Volumn 2, Issue 12, 2011, Pages 760-768

  Van Den Berg, Suzanne J P L ^a   Serra Majem, Lluis ^b,c   Coppens, Patrick ^d   Rietjens, Ivonne M C M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d European Botanical Forum   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EUROPEAN FOOD SAFETY AUTHORITIES; FOOD SUPPLEMENTS; MARKET VOLUME; REGULATION AND CONTROL; REGULATORY BODIES; SAFETY ASSESSMENTS;

NUTRITION; SAFETY ENGINEERING;

PLANTS (BOTANY);

CARCINOGEN; MUTAGENIC AGENT; PLANT MEDICINAL PRODUCT;

ANIMAL; DIET SUPPLEMENTATION; EUROPE; FOOD CONTAMINATION; FOOD SAFETY; HERB DRUG INTERACTION; HUMAN; LAW; LEGAL ASPECT; PLANT; REVIEW; RISK ASSESSMENT;

ANIMALS; CARCINOGENS; DIETARY SUPPLEMENTS; EUROPE; FOOD CONTAMINATION; FOOD SAFETY; HERB-DRUG INTERACTIONS; HUMANS; LEGISLATION, FOOD; MUTAGENS; PLANT PREPARATIONS; PLANTS, EDIBLE; RISK ASSESSMENT;

EID: 82455167181     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c1fo10067j     Document Type: Review

References (65)

1. Discussion paper on botanicals and botanical preparations widely used as food supplements and related products: coherent and comprehensive risk assessment and consumer information approaches, EFSA, Brussels, 2004. URL: http://www.efsa.europa.eu/fr/efsajournal/doc/1249.pdf
2. D. A. Taylor Environ. Health Perspect. 2004 112 A750 A753
3. Draft guidance document of the Scientific Committee for the safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements, EFSA, 2007, URL: http://www.oeti.hu/download/ sc-guidance-bota-public-consultation.pdf
4. Advice on the EFSA guidance document for the safety assessment of botanicals and botanical preparations intended for use as food supplements, based on real case studies, EFSA, Parma, 2009. URL: http://www.efsa.europa.eu/ en/supporting/doc/280r.pdf
5. G. Speijers B. Bottex B. Dusemund A. Lugasi J. Toth J. Amberg-Muller C. L. Galli V. Silano I. M. C. M. Rietjens Mol. Nutr. Food Res. 2010 54 175 185
6. Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements, EFSA, 2009. URL: http://www.efsa.europa.eu/fr/efsajournal/doc/1249.pdf
7. E. S. D. Johanns L. E. van der Kolk H. M. A. van Gemert A. E. Sijben P. W. Peters I. de Vries Ned. Tijdschr. Geneeskd. 2002 146 813 816
8. A. M. Oudesluys-Murphy N. Oudesluys Lancet 2002 360 878
9. G. J. Biessels F. H. Vermeij F. S. S. Leijten Ned. Tijdschr. Geneeskd. 2002 146 808 811
10. M. Vanhaelen R. Vanhaelen-Fastre P. But J. L. Vanherweghem Lancet 1994 343 174
11. J. L. Vanherweghem M. Depierreux C. Tielemans D. Abramowicz M. Dratwa M. Jadoul C. Richard D. Vandervelde D. Verbeelen R. Vanhaelen-Fastre et al. Lancet 1993 341 387 391
12. Safety evaluation of certain food additives, prepared by the 51st meeting of JECFA, FAS 42-JECFA 51/5, JECFA, 1998
13. G. M. Cramer R. A. Ford R. L. Hall Food Cosmet. Toxicol. 1976 16 255 276
14. I. C. Munro R. A. Ford E. Kennepohl J. G. Sprenger Food Chem. Toxicol. 1996 34 829 867
15. I. C. Munro E. Kennepohl R. Kroes Food Chem. Toxicol. 1999 37 207 232
16. R. Kroes A. G. Renwick V. Feron C. L. Galli M. Gibney H. Greim R. H. Guy J. C. Lhuguenot J. J. M. van de Sandt Food Chem. Toxicol. 2007 45 2533 2562
17. Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic, EFSA, 2005. URL: http://www.efsa.europa.eu/en/efsajournal/doc/ 282.pdf
18. S. Barlow J. Schlatter Toxicol. Appl. Pharmacol. 2010 243 180 190
19. S. Barlow A. G. Renwick J. Kleiner J. W. Bridges L. Busk E. Dybing L. Edler G. Eisenbrand J. Fink-Gremmels A. Knaap R. Kroes D. Liem D. J. G. Muller S. Page V. Rolland J. Schlatter A. Tritscher W. Tueting G. Wurtzen Food Chem. Toxicol. 2006 44 1636 1650
20. J. O'Brien A. G. Renwick A. Constable E. Dybing D. J. G. Muller J. Schlatter W. Slob W. Tueting J. van Benthem G. M. Williams A. Wolfreys Food Chem. Toxicol. 2006 44 1613 1635
21. Summary and conclusions of the sixty-fourth meeting of JECFA, JECFA, Rome, 2005, URL: ftp://ftp.fao.org/es/esn/jecfa/jecfa64-summary.pdf
22. R. Kroes A. G. Renwick M. Cheeseman J. Kleiner I. Mangelsdorf A. Piersma B. Schilter J. Schlatter F. van Schothorst J. G. Vos G. Wurtzen Food Chem. Toxicol. 2004 42 65 83
23. Compendium of botanicals that have been reported to contain toxic, addictive, psychotropic or other substances of concern on request of EFSA, EFSA, Parma, 2009. URL: http://www.efsa.europa.eu/en/supporting/doc/280rax1.pdf
24. I. M. C. M. Rietjens M. J. Martena M. G. Boersma W. Spiegelenberg G. M. Alink Mol. Nutr. Food Res. 2005 49 131 158
25. IPCS environmental health criteria 80, Pyrrolizidine alkaloids, WHO, 1988, URL: http://www.inchem.org/documents/ehc/ehc/ehc080.htm
26. Koninklijk besluit van 29 augustus 1997 betreffende de fabricage van en de handel in voedingsmiddelen die uit planten of plantenbereidingen samengesteld zijn of deze bevatten, Belgian State Journal, 21 November 1997, URL: http://www.bbkbio.be/pdf/KB290897-geconsolideerde-versie-op-28022005-NL.pdf
27. The Medicines (Products Other Than Veterinary Drugs) (General Sale List), Amendment Order 1994 no. 2410, United Kingdom, 1994. URL: http://www. legislation.gov.uk/uksi/1994/2410/made
28. Regulations relating to the prohibition of comfrey and comfrey containing foodstuffs and jelly confectionery containing konjac in foodstuffs-Foodstuffs, Cosmetics and Disinfectants Act (54/1972), South African Department of Health, 2002, URL: http://www.doh.gov.za/docs/regulations/2002/reg1541.html
29. Standard 1.4.4 prohibited and restricted plants and fungi, Australia New Zealand Food Standards, 2009, URL: http://www.comlaw.gov.au/Details/F2009C00806
30. Besluit van 19 januari 2001, Houdende vaststelling van het Warenwetbesluit Kruidenpreparaten, Staatsblad van het Koninkrijk der Nederlanden, 2001, 56, 1-12
31. Bundesrepublik Deutschland/pyrrolizidine alkaloide, stufe ii abwehr von arzneimittelrisiken, Pharm. Ztg. 1992, 137, 2088-2089
32. FDA Advises Dietary Supplement Manufacturers to Remove Comfrey Products From the Market, FDA, 2001, URL: http://www.fda.gov/Food/DietarySupplements/ Alerts/ucm111219.htm
33. Health Canada advises consumers not to use or ingest the herb comfrey or health products that contain comfrey, Health Canada, 2003, http://www.hc-sc.gc. ca/dhp-mps/medeff/advisories-avis/public/-2003/index-eng.php
34. S. M. F. Jeurissen A. Punt M. G. Boersma J. J. Bogaards Y. C. Fiamegos B. Schilter P. J. van Bladeren N. H. Cnubben I. M. C. M. Rietjens Chem. Res. Toxicol. 2007 20 798 806
35. D. H. Phillips J. A. Miller E. C. Miller B. Adams Cancer Res. 1981 41 176 186
36. R. L. Smith T. B. Adams J. Doull V. J. Feron J. I. Goodman L. J. Marnett P. S. Portoghese W. J. Waddell B. M. Wagner A. E. Rogers J. Caldwell I. G. Sipes Food Chem. Toxicol. 2002 40 851 870
37. R. W. Wiseman T. R. Fennell J. A. Miller E. C. Miller Cancer Res. 1985 45 3096 3105
38. R. W. Wiseman E. C. Miller J. A. Miller A. Liem Cancer Res. 1987 47 2275 2283
39. M. J. Martena J. C. A. van der Wielen L. F. J. van de Laak E. J. M. Konings H. N. de Groot I. M. C. M. Rietjens Anal. Bioanal. Chem. 2007 389 263 275
40. G. Gillerot M. Jadoul V. M. Arlt C. van Ypersele De Strihou H. H. Schmeiser P. P. But C. A. Bieler J. P. Cosyns Am. J. Kidney Dis. 2001 38 E26
41. P. Shekelle M. L. Hardy S. C. Morton M. Maglione M. Suttorp E. Roth L. Jungvig W. A. Mojica J. Gagne S. Rhodes E. McKinnon Evid. Rep. Technol. Assess. (Summ.) 2003 1 4
42. G. Calapai F. Firenzuoli A. Saitta F. Squadrito M. R. Arlotta G. Costantino G. Inferrera Fitoterapia 1999 70 586 592
43. S. Jack T. Desjarlais-Renaud K. Pilon Can. Adverse React. Newslett. 2007 17 2 3
44. E. Kakemoto E. Okuyama K. Nagata Y. Ozoe Biochem. Pharmacol. 1999 58 617 621
45. K. M. Hold N. S. Sirisoma T. Ikeda T. Narahashi J. E. Casida Proc. Natl. Acad. Sci. U. S. A. 2000 97 3826 3831
46. L. Schelosky C. Raffauf K. Jendroska W. Poewe J. Neurol., Neurosurg. Psychiatry 1995 58 639 640
47. J. J. Spollen S. M. Spollen J. S. Markowitz J. Pharm. Pract. 1999 12 196 209
48. B. M. Johnson S. X. Qiu S. Zhang F. Zhang J. E. Burdette L. Yu J. L. Bolton R. B. van Breemen Chem. Res. Toxicol. 2003 16 733 740
49. P. A. Whitton A. Lau A. Salisbury J. Whitehouse C. S. Evans Phytochemistry 2003 64 673 679
50. M. Escher J. Desmeules E. Giostra G. Mentha Br. Med. J. 2001 322 139
51. Centers for disease and cancer prevention, MMWR Morb. Mortal Week. Rep., 2002, 51, 1065-1067
52. Import Alert 62-01, FDA, 2009, URL: http://www.accessdata.fda.gov/cms-ia/ importalert-167.html
53. Statutory Instrument (SI) 1984:87, The Medicines (Cyanogenetic Substances) Order 1984 no. 187, United Kingdom, 1984, URL: http://www. legislation.gov.uk/uksi/1984/187/made
54. Sale of Drugs (Prohibited Drugs) (Consolidation) Regulations, Health Sciences Authority, Singapore, 1985, URL: http://www.hsa.gov.sg/publish/etc/ medialib/hsa-library/health-products-regulation/legislation/sale-of-drugs-act. Par.6933.File.dat/SALE%20OF%20DRUGS%20(PROHIBITED%20DRUGS)%20(CONSOLIDATION) %20REGULATIONS.pdf
55. Opinion of the Scientific Panel on Food additives, Flavourings, processing aids and materials in contact with food (AFC), on a request from the commission related to Coumarin, EFSA, The EFSA Journal, 2004, 104, 1 36. URL: http://www.efsa.europa.eu/en/scdocs/doc/104.pdf
56. S. S. Chatterjee S. K. Bhattacharya M. Wonnemann A. Singer W. E. Muller Life Sci. 1998 63 499 510
57. B. J. Gurley S. F. Gardner M. A. Hubbard D. K. Williams W. B. Gentry Y. Cui C. Y. W. Ang Drugs Aging 2005 22 525 539
58. J. S. Markowitz J. L. Donovan C. L. DeVane R. M. Taylor Y. Ruan J. S. Wang K. D. Chavin JAMA, J. Am. Med. Assoc. 2003 290 1500 1504
59. R. H. Mathijssen J. Verweij P. de Bruijn W. J. Loos A. Sparreboom J. Natl. Cancer Inst. 2002 94 1247 1249
60. S. C. Piscitelli A. H. Burstein D. Chaitt R. M. Alfaro J. Falloon Lancet 2000 355 547 548
61. Public Health Advisory, FDA, February 10, 2000, URL: http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm052238. htm
62. L. Chen M. J. Lee H. Li C. S. Yang Drug Metab. Dispos. 1997 25 1045 1050
63. W. D. Johnson R. L. Morrissey J. A. Crowell D. L. McCormick Toxicologist 1999 48 57 58
64. W. Alhusainy A. Paini A. Punt J. Louisse A. Spenkelink J. Vervoort T. Delatour G. Scholz B. Schilter T. Adams P. J. van Bladeren I. M. C. M. Rietjens Toxicol. Appl. Pharmacol. 2010 245 179 190
65. S. M. F. Jeurissen A. Punt T. Delatour I. M. C. M. Rietjens Food Chem. Toxicol. 2008 46 2296 2302